search icon
Join IDSAJOIN IDSA >> Go to MyIDSAGO TO MYIDSA >>
  • Print
  • ShareThis
  • Text Size
  • Global Health

    IDSA prioritizes promoting sufficient U.S. investment in global infectious diseases responses and research, and in using the voices of physician scientists to inform multilateral and national global health policies. IDSA is a trusted leader in shaping and advancing international and national policies and investments in global HIV, TB, health security and antimicrobial resistance.

    What's New?

     

    Statement on World AIDS Day 2017 12/01/2017
    On World AIDS Day, while we recognize the progress made against
    HIV globally, we must measure that progress against the
    urgent needs that remain. Click here to read more. 

    Countdown: Global HIV, Responses, Results 12/1/2017
    This briefing paper from IDSA chronicles the progress made over the past
    decade in eliminating HIV/AIDS as a global public health threat, and looks
    ahead at the work that remains in achieving epidemic control. Click here to read more.

    Red Ribbon or White Flag? The Future of the US Global AIDS Response 12/01/2017
    This report from the ONE campaign details the impacts of the White House’s
    proposed budget cuts to U.S. global HIV funding and subsequent PEPFAR
    strategy on the global AIDS response. Click here to read more. 

    The Ascent Begins: Tuberculosis Research Funding Trends, 2005-2016 11/08/2017
    The latest report from the Treatment Action Group on funding trends for global
    tuberculosis research and development shows there has been increases in
    spending on TB research, but overall funding remains inadequate for achieving
    global goals to eliminate the epidemic by 2030. Click here to read more.

    Healthier World, Safer America: A U.S. Government Roadmap 
    for International Action to Prevent the Next Pandemic 10/24/2017
    The latest report from the Treatment Action Group on funding trends for global
    tuberculosis research and development shows there has been increases in
    spending on TB research, but overall funding remains inadequate
    for achieving global goals to eliminate the epidemic by 2030. 
    Click here to read more.  

    Read More About What's New in Global Health 

    12/1/2017

    Statement on World AIDS Day 2017

    On World AIDS Day, while we recognize the progress made against HIV globally, we must measure that progress against the urgent needs that remain. 

    12/1/2016

    World AIDS Day 2016

    This World AIDS Day finds us at a pivotal moment, appreciating the progress that has led to 18 million people worldwide receiving treatment that prevents illness and transmission of HIV and accepting the challenge of extending that essential intervention to the 15 million living with HIV still in need of medicine. 

    10/13/2016

    Statement on WHO 2016 Global TB report

    Washington, DC, October 13, 2016 — Today the World Health Organization released new data
    showing that the tuberculosis (TB) epidemic is worse than previously known, with over 10 million
    people falling sick last year.
    3/23/2016

    Commemorate progress, seize opportunities on World TB Day

    We commemorate World TB Day faced with unprecedented challenges and opportunities in the fight against a disease first named 134 years ago today.

    9/4/2017

    IDSA & HIVMA Letter on NDAA

    Dear Senators McCain and Reed:
    We are writing on behalf of the Infectious Diseases Society of America (IDSA) and the HIV Medicine Association (HIVMA) to express our opposition to provisions in S. 1519, The National Defense Authorization Act for Fiscal Year 2018 that would impose severe restrictions on medical research funded through the Department of Defense (DoD) and impose onerous requirements on research grant recipients.
    8/29/2017

    IDSA Letter to new USAID Administrator

    Dear Administrator Green,
    The Infectious Diseases Society of America extends our congratulations on your confirmation as Administrator of the U.S. Agency for International Development.
    8/29/2017

    IDSA Letter to New WHO Director General

    Dear Dr. Tedros,
    The Infectious Diseases Society of America extends our congratulations on your election as Director General of the World Health Organization.
    7/21/2017

    IDSA Letter on Moscow TB Declaration

    Dear Intergovernmental Working Group,
    The Infectious Diseases Society of America commends your efforts to foster robust political support for ending the global tuberculosis epidemic by developing the draft Moscow Declaration for the WHO Global Ministerial Conference on Ending Tuberculosis in advance of the November meeting.
    5/11/2017

    Report on CROI 2017

    Launched in 1993 as a forum for basic scientists and clinical investigators from around the world to share and discuss laboratory science, clinical trials and evolving practice confronting HIV and its associated impacts, the Conference on Retroviruses and Opportunistic Infections has provided the setting for presentations of landmark research heralding advances against the pandemic.

    5/11/2017

    Report on 47th Union World Conference on Lung Health

    The resistance that enabled tuberculosis to resurge from a sickness considered all but conquered in the last century, to one that in this century kills more people than any other infectious disease on earth, goes beyond the mutations of the bacteria that survive initial treatment.

    4/26/2017

    Fogarty International Center

    The Fogarty International Center, founded in 1968 and part of the National Institutes of Health, connects American scientists and health-care professionals with their global health peers to support basic, clinical, and applied research along with training programs in low-and middle-income countries.
    4/26/2017

    Updated Zika White Paper 2017

    Before the 2015 arrival of Zika virus in the Western Hemisphere, a mosquito bite had never before been linked to a devastating birth defect.

    12/1/2017

    Red Ribbon or White Flag? The Future of the US Global AIDS Response

    This report from the ONE campaign details the impacts of the White House’s proposed budget cuts to U.S. global HIV funding and subsequent PEPFAR strategy on the global AIDS response. .  

    10/24/2017

    Healthier World, Safer America: A U.S. Government Roadmap for International Action to Prevent the Next Pandemic

    This report from PATH analyzes the importance of developing a robust pipeline of new drugs, diagnostics, vaccines and other technologies for diseases likely to become pandemics, and outlines recommendations for action from the U.S. government to prevent the next pandemic. 

    11/8/2017

    The Ascent Begins: Tuberculosis Research Funding Trends, 2005-2016

    The latest report from the Treatment Action Group on funding trends for global tuberculosis research and development shows there has been increases in spending on TB research, but overall funding remains inadequate for achieving global goals to eliminate the epidemic by 2030.  

| HIVMA | Contact Us

© Copyright IDSA 2017 Infectious Diseases Society of America

Full Site Mobile Site